Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants

Go Back to All Clinical Trials

Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Preterm Infants Admitted To The Neonatal Intensive Care Unit
Age: Between 0 Day(s) - 4 Month(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Any preterm infants (< 37 weeks gestation, n=60) and any term infants (>37 weeks gestation, n=20) admitted to the NYU Winthrop Hospital NICU

You may not be eligible for this study if the following are true:

1. Any preterm infants (< 37 weeks gestation, n=60) and any term infants (>37 weeks gestation, n=20) admitted to the NYU Winthrop Hospital NICU

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies